Apollomics Total Assets from 2010 to 2026
| APLM Stock | 17.92 1.95 9.81% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 11.8 M | Current Value 11.2 M | Quarterly Volatility 38.6 M |
Check Apollomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apollomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.6 K, Interest Expense of 114.2 K or Gross Profit of 216.3 K, as well as many indicators such as Price To Sales Ratio of 49.84, Dividend Yield of 0.0 or PTB Ratio of 1.75. Apollomics financial statements analysis is a perfect complement when working with Apollomics Valuation or Volatility modules.
Apollomics | Total Assets | Build AI portfolio with Apollomics Stock |
Latest Apollomics' Total Assets Growth Pattern
Below is the plot of the Total Assets of Apollomics Class A over the last few years. Total assets refers to the total amount of Apollomics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Apollomics Class A books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Apollomics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apollomics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 13.1 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Apollomics Total Assets Regression Statistics
| Arithmetic Mean | 73,638,529 | |
| Geometric Mean | 59,491,052 | |
| Coefficient Of Variation | 52.35 | |
| Mean Deviation | 23,892,015 | |
| Median | 79,053,000 | |
| Standard Deviation | 38,550,067 | |
| Sample Variance | 1486.1T | |
| Range | 158.7M | |
| R-Value | (0.39) | |
| Mean Square Error | 1340.7T | |
| R-Squared | 0.15 | |
| Significance | 0.12 | |
| Slope | (2,997,871) | |
| Total Sum of Squares | 23777.7T |
Apollomics Total Assets History
Other Fundumenentals of Apollomics Class A
Apollomics Total Assets component correlations
Click cells to compare fundamentals
About Apollomics Financial Statements
Apollomics investors utilize fundamental indicators, such as Total Assets, to predict how Apollomics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 11.8 M | 11.2 M | |
| Intangibles To Total Assets | 0.12 | 0.10 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Apollomics Correlation against competitors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Biotechnology sector continue expanding? Could Apollomics diversify its offerings? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apollomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (52.80) | Revenue Per Share | Quarterly Revenue Growth 2.623 | Return On Assets | Return On Equity |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Apollomics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apollomics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Apollomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.